response to conventional glucocorticoid and immunosuppressant therapy and has a poor overall prognosis. 2We highlight this case to sensitize the physicians about the typical cutaneous findings and ILD that clinch the diagnosis.
No takes yet. Share an insight, caveat, or question.
Goel et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: